“Nobiletin Acts As a Potential Anticancer Agent Against Osteosarcoma by Regulating ERK and AKT Signaling Pathways”. Bangladesh Journal of Pharmacology, vol. 9, no. 3, Sept. 2014, pp. 406-12, https://doi.org/10.3329/bjp.v9i3.19567.